Ixazomib - Takeda Oncology
At a glance
- Drug Originator Millennium Pharmaceuticals; University of California, San Diego
- Drug Class Amides; Antineoplastics; Antivirals; Chlorobenzenes; Organic boron compounds; Small molecules
- Mechanism of Action Apoptosis stimulants; Proteasome inhibitors
- USA Patent Applicants TAKEDA PHARMS USA
- USA Patents 14
- NDAs 1
- International Patents 185
Table of Contents
Disclaimer